EGRP's Organizational Structure
Our organization consists of the Office of the Associate Director (OAD) and five Branches that oversee and facilitate research to understand the determinants of cancer occurrence and outcomes in human populations.
The Office of the Associate Director (OAD) develops and implements the mission and scientific and strategic agenda of the Epidemiology and Genetics Research Program (EGRP). The OAD integrates and coordinates the activities of the component Branches by establishing program priorities, allocating resources, staff, and assignments; and manages scientific activities and portfolios that cross Branch boundaries.
Freedman, Andrew N., Ph.D.
Clinical and Translational Epidemiology Branch
- Prediction models for cancer outcomes
- Benefit/risk indices for oncology drugs
- Clinical, epidemiologic, and pharmacogenomic factors related to cancer treatment outcomes
Gillanders, Elizabeth M., Ph.D.
Genomic Epidemiology Branch
- Genetic epidemiology of cancer
- Innovative methods for genetic epidemiology
- Genetic architecture of cancer across populations
- Genetic heterogeneity of high-risk cancer families
- Secondary analyses of genetic data
- Patient engagement and Cancer Genome Sequencing
Verma, Mukesh, Ph.D.
Methods and Technologies Branch
- Biomarkers of risk and detection
- Epigenetics and epidemiology
- High throughput technologies in epidemiology
- Multi-Omics technologies (proteomics, transcriptomics, metabolomics)